Form 4: Viemed Healthcare President Michael Moore Reports Share Transactions

Viemed Healthcare's President, Michael Moore, reported multiple transactions involving common shares and derivative securities, including the vesting of restricted stock units and phantom share units.

Summary

• Michael Moore, President of Viemed Healthcare, reported several transactions on January 17th and 18th, 2025.
• These transactions include the acquisition of 26,939 common shares through the vesting of restricted stock units, and the acquisition of 6,735 and 9,488 common shares through the vesting of phantom share units.
• He also disposed of 8,762 shares to cover tax obligations related to the vesting of restricted stock units.
• The price per share for the transactions was $8.15.
• Additionally, Moore was granted 102,642 restricted stock units and 25,661 phantom share units on January 21, 2025, which vest over three years.
• Moore also has indirect ownership of 1,722,614 common shares through Moore Faster LLC.

Sentiment

Score: 7

Explanation: The document reflects standard insider transactions related to compensation. The vesting of shares and grants of new units are positive indicators of performance and confidence, but the tax related disposals are neutral.

Positives

• The vesting of restricted stock units and phantom share units indicates that performance targets were met.
• The grant of new restricted stock units and phantom share units suggests continued confidence in the company's future performance.

Negatives

• The disposal of 8,762 shares to cover tax obligations could be seen as a minor negative, although it is a standard practice.

Risks

• The value of the phantom share units is tied to the company's share price, which could fluctuate.
• The vesting of the restricted stock units and phantom share units is contingent on continued employment and performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider transactions and is typical for publicly traded companies. It provides transparency into the stock ownership of key executives.

Comparison to Industry Standards

• The vesting of restricted stock units and phantom share units is a common practice for executive compensation in publicly traded companies.
• The reporting of these transactions via SEC Form 4 is standard procedure and ensures compliance with regulations.
• The vesting schedules of three equal annual installments are also typical for such grants.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect the standard vesting of executive compensation.
• The vesting of shares and grants of new units are positive indicators of performance and confidence.

Key Dates

Keywords

Viemed Healthcare, Michael Moore, stock transactions, restricted stock units, phantom share units, insider trading, SEC Form 4, share vesting